Identifying Clinical Predictors of Unfavorable Treatment Trajectories in Major Depressive Disorder: A National Multicentered Prospective Cohort Longitudinal, Naturalistic Study.
Аннотация
BACKGROUND
While antidepressant side effects are often expected to diminish with continued treatment, empirical evidence remains limited. This study investigates co-trajectories of depressive severity with side-effect burden (SEB) and associated factors in patients with major depressive disorder (MDD).
METHODS
We analyzed longitudinal data from 1377 MDD outpatients across three Chinese multicenter studies (2015-2022), with assessments at baseline, weeks 2, 4, 8, 12, and 24. Depression severity was measured using the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16). At the same time, SEB was quantified using the frequency, intensity, and burden of side effects rating (FIBSER). Dual-trajectory modeling was used to identify distinct SEB and depression severity trajectories, with linear mixed-effects models comparing depression changes across SEB groups.
RESULTS
Four SEB trajectories were identified: no SEB (41.5%), early-onset SEB (29.1%), late-onset SEB (14.7%), and persistent SEB (13.9%). Depressive severity followed three trajectories: mild-responsive (66.6%), moderate-progressive (18.7%), and chronic-severe (14.7%). Persistent SEB was associated with higher baseline depression severity (OR = 1.13, 95% CI: 1.08-1.17), antidepressant combination (OR = 3.7, 95% CI: 1.52- 9.02), and poorer treatment outcomes. 7.3% exhibited concurrent chronic-severe depressive severity and persistent SEB. Female (OR = 1.95, 95% CI: 1.11-3.42), younger age (OR = 5.02, 95% CI: 2.63-9.55), higher education (high school: OR = 2.5, 95% CI: 1.12-5.36; bachelor and above: OR = 2.68, 95% CI: 1.24-5.82), and combination antidepressant (OR = 8.27, 95% CI: 2.69-25.45) were significant risk factors for concurrent severe symptoms and persistent SEB.
CONCLUSION
Persistent antidepressant side effects coevolve with unfavorable depression trajectories over 6 months. Clinicians should prioritize early monitoring and tailored interventions for high-risk subgroups, particularly those with severe baseline symptoms or on combination therapy. These findings underscore the importance of continuous monitoring and personalized interventions to manage antidepressant side effects effectively.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.